We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$429B
AUM Growth
-$876M
Cap. Flow
-$469M
Cap. Flow %
-0.11%
Top 10 Hldgs %
29.86%
Holding
460
New
23
Increased
187
Reduced
164
Closed
19

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$1.13B
2
SE icon
Sea Limited
SE
+$1.11B
3
AMZN icon
Amazon
AMZN
+$958M
4
MS icon
Morgan Stanley
MS
+$871M
5
PCG icon
PG&E
PCG
+$840M

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$1.35B
2
MA icon
Mastercard
MA
+$1.22B
3
JPM icon
JPMorgan Chase
JPM
+$1.09B
4
VALE icon
Vale
VALE
+$724M
5
FANG icon
Diamondback Energy
FANG
+$724M

Sector Composition

Rank Sector Weight
1 Technology 20.89%
2 Communication Services 15.06%
3 Healthcare 14.45%
4 Consumer Discretionary 13.58%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
451
Madrigal Pharmaceuticals
MDGL
$12.4B
-466,422
Closed -$45.4M
PATH icon
452
UiPath
PATH
$7.95B
-75,000
Closed -$5.09M
WFC icon
453
Wells Fargo
WFC
$267B
-4,796,509
Closed -$217M
WYNN icon
454
Wynn Resorts
WYNN
$10.6B
-904,612
Closed -$111M
CMLS
455
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-33,691
Closed -$494K
AYX
456
DELISTED
Alteryx Inc
AYX
-774,412
Closed -$66.6M
NUAN
457
DELISTED
Nuance Communications, Inc.
NUAN
-649,275
Closed -$35.3M
PRAH
458
DELISTED
PRA Health Sciences, Inc.
PRAH
-2,298,597
Closed -$380M
QADA
459
DELISTED
QAD Inc.
QADA
-728,879
Closed -$63.4M

Similar funds

Capital Research Global Investors's Q3 2021 Portfolio in Review

As of Q3 2021, Capital Research Global Investors held 460 positions worth $429B, down 0.2% from $430B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Capital Research Global Investors's Q3 2021 filing shows 23 new, 187 increased, 164 reduced and 19 closed positions. Its largest new stake was Block Inc: 1,884,689 shares worth $452M. The largest sale was EOG Resources, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.

  • Capital Research Global Investors's largest Q3 2021 buy was Block Inc: 1,884,689 shares worth $452M.
  • Capital Research Global Investors added most to GE Aerospace in Q3 2021, an estimated $1.13B increase.
  • Capital Research Global Investors's biggest Q3 2021 reduction was EOG Resources, cutting an estimated $1.35B.
  • Capital Research Global Investors fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $380M.
  • Capital Research Global Investors's ten largest holdings make up 30% of its $429B portfolio in Q3 2021.
  • Capital Research Global Investors opened 23 new positions and closed 19 in Q3 2021.
  • Capital Research Global Investors's portfolio value fell 0.2% quarter-over-quarter to $429B.

Based on Capital Research Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.